AZN
AstraZeneca PLC
NASDAQ: AZN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$187.37
+1.17% today
Updated 2026-04-30
Market cap
$294.17B
P/E ratio
28.97
P/S ratio
5.01x
EPS (TTM)
$6.55
Dividend yield
1.66%
52W range
$130 – $211
Volume
2.0M
AstraZeneca PLC (AZN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $29.93B | $47.96B | $46.95B | $54.92B | $56.13B | $52.83B | $53.53B | $55.90B | $58.59B | $60.12B | $62.53B | $63.35B | $60.65B | $61.38B | $66.73B | $105.36B | $96.48B | $101.12B | $104.03B | $114.07B |
| Cash & equivalents | $7.10B | $5.87B | $4.29B | $9.92B | $11.07B | $7.57B | $7.70B | $9.22B | $6.36B | $6.24B | $5.02B | $3.32B | $4.83B | $5.37B | $7.83B | $6.33B | $6.17B | $5.84B | $5.49B | $5.71B |
| Current assets | $16.94B | $17.08B | $15.87B | $23.76B | $25.13B | $23.51B | $19.05B | $20.34B | $16.70B | $16.01B | $13.26B | $13.15B | $15.59B | $15.56B | $19.54B | $26.24B | $22.59B | $25.05B | $25.83B | $28.72B |
| Total liabilities | $14.52B | $33.04B | $30.89B | $34.10B | $32.72B | $29.36B | $29.58B | $32.65B | $38.95B | $41.62B | $45.86B | $46.71B | $46.61B | $46.78B | $51.09B | $66.08B | $59.42B | $61.95B | $63.16B | $65.36B |
| Current liabilities | $9.45B | $15.19B | $13.41B | $17.64B | $16.79B | $15.75B | $13.90B | $16.05B | $17.33B | $14.87B | $15.26B | $16.38B | $16.29B | $18.12B | $20.31B | $22.59B | $26.29B | $30.54B | $27.87B | $30.62B |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $28.13B | $22.96B | $22.36B | $26.51B | $24.71B |
| Shareholder equity | $15.30B | $14.78B | $15.91B | $20.66B | $23.21B | $23.25B | $23.74B | $23.22B | $19.63B | $18.49B | $14.85B | $14.96B | $12.47B | $13.13B | $15.62B | $39.27B | $37.04B | $39.14B | $40.79B | $48.67B |
| Retained earnings | $11.35B | $10.62B | $11.57B | $16.20B | $18.27B | $17.89B | $17.96B | $16.96B | $13.03B | $11.83B | $8.14B | $8.22B | $5.68B | $2.81B | $5.30B | $1.71B | $-574.00M | $4.52B | $3.16B | $10.97B |
| Accounts receivable | $5.56B | $6.67B | $10.86B | $-24.00M | $10.89B | $8.75B | $7.63B | $5.51B | $4.76B | $4.63B | $2.58B | $2.80B | $3.00B | $4.90B | $5.65B | $8.13B | $9.19B | $8.41B | $11.23B | $15.18B |
| Inventory | $2.25B | $2.12B | $1.64B | $1.75B | $1.68B | $1.85B | $2.06B | $1.91B | $1.96B | $2.14B | $2.33B | $3.04B | $2.89B | $3.19B | $4.02B | $8.98B | $4.70B | $5.42B | $5.29B | $6.56B |
| Goodwill | $1.10B | $9.88B | $9.87B | $9.89B | $9.87B | $9.86B | $9.90B | $9.98B | $11.55B | $11.87B | $11.66B | $11.82B | $11.71B | $11.67B | $11.85B | $20.00B | $19.82B | $20.05B | $21.02B | $21.24B |